We are international
Donate
• health professionals TEXT SIZE   
webcasts    back

Effect of the combination of pegylated liposomal doxorubicin and bortezomib on time to progression (TTP) and overall survival of patients with relapsed/refractory multiple myeloma compared with bortezomib alone.
06.10.07
Click here to see video


 related articles